These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33133147)

  • 1. Novel Splicing Variant in the
    Slaba K; Noskova H; Vesela P; Tuckova J; Jicinska H; Honzik T; Hansikova H; Kleiblova P; Stourac P; Jabandziev P; Slaby O; Prochazkova D
    Front Genet; 2020; 11():561054. PubMed ID: 33133147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A PMM2-CDG caused by an A108V mutation associated with a heterozygous 70 kilobases deletion case report.
    Lebredonchel E; Riquet A; Neut D; Broly F; Matthijs G; Klein A; Foulquier F
    Ital J Pediatr; 2022 Oct; 48(1):178. PubMed ID: 36221102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PMM2-CDG caused by uniparental disomy: Case report and literature review.
    Vaes L; Tiller GE; Pérez B; Boyer SW; Berry SA; Sarafoglou K; Morava E
    JIMD Rep; 2020 Jul; 54(1):16-21. PubMed ID: 32685345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypes and estimated prevalence of phosphomannomutase 2 deficiency in Turkey differ significantly from those in Europe.
    Yıldız Y; Arslan M; Çelik G; Kasapkara ÇS; Ceylaner S; Dursun A; Sivri HS; Coşkun T; Tokatlı A
    Am J Med Genet A; 2020 Apr; 182(4):705-712. PubMed ID: 31981409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular ring anomaly in a patient with phosphomannomutase 2 deficiency: A case report and review of the literature.
    Qian Z; Van den Eynde J; Heymans S; Mertens L; Morava E
    JIMD Rep; 2020 Nov; 56(1):27-33. PubMed ID: 33204593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-functional alternative splicing caused by a Latino pathogenic variant in a case of PMM2-CDG.
    González-Domínguez CA; Villarroel CE; Rodríguez-Morales M; Manrique-Hernández S; González-Jaimes A; Olvera-Rodriguez F; Beutelspacher K; Molina-Garay C; Carrillo-Sánchez K; Flores-Lagunes LL; Jiménez-Olivares M; Muñoz-Rivas A; Cruz-Muñoz ME; Mora-Montes HM; Salinas-Marín R; Alaez-Verson C; Martínez-Duncker I
    Mol Genet Metab Rep; 2021 Sep; 28():100781. PubMed ID: 34277356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature.
    Schiff M; Roda C; Monin ML; Arion A; Barth M; Bednarek N; Bidet M; Bloch C; Boddaert N; Borgel D; Brassier A; Brice A; Bruneel A; Buissonnière R; Chabrol B; Chevalier MC; Cormier-Daire V; De Barace C; De Maistre E; De Saint-Martin A; Dorison N; Drouin-Garraud V; Dupré T; Echenne B; Edery P; Feillet F; Fontan I; Francannet C; Labarthe F; Gitiaux C; Héron D; Hully M; Lamoureux S; Martin-Coignard D; Mignot C; Morin G; Pascreau T; Pincemaille O; Polak M; Roubertie A; Thauvin-Robinet C; Toutain A; Viot G; Vuillaumier-Barrot S; Seta N; De Lonlay P
    J Med Genet; 2017 Dec; 54(12):843-851. PubMed ID: 28954837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification through exome sequencing of the first PMM2-CDG individual of Mexican mestizo origin.
    González-Domínguez CA; Raya-Trigueros A; Manrique-Hernández S; González Jaimes A; Salinas-Marín R; Molina-Garay C; Carrillo-Sánchez K; Flores-Lagunes LL; Jiménez-Olivares M; Dehesa-Caballero C; Alaez-Versón C; Martínez-Duncker I
    Mol Genet Metab Rep; 2020 Dec; 25():100637. PubMed ID: 32874916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and whole-exome sequencing findings in two siblings from Hani ethnic minority with congenital glycosylation disorders.
    Zhang Z; Huang TL; Ma J; He WJ; Gu H
    BMC Med Genet; 2019 Nov; 20(1):181. PubMed ID: 31727010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal outcome after heart surgery in PMM2-CDG due to a rare homozygous gene variant with double effects.
    Görlacher M; Panagiotou E; Himmelreich N; Hüllen A; Beedgen L; Dimitrov B; Geiger V; Zielonka M; Peters V; Strahl S; Vázquez-Jiménez J; Kerst G; Thiel C
    Mol Genet Metab Rep; 2020 Dec; 25():100673. PubMed ID: 33209585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten years of screening for congenital disorders of glycosylation in Argentina: case studies and pitfalls.
    Asteggiano CG; Papazoglu M; Bistué Millón MB; Peralta MF; Azar NB; Spécola NS; Guelbert N; Suldrup NS; Pereyra M; Dodelson de Kremer R
    Pediatr Res; 2018 Dec; 84(6):837-841. PubMed ID: 30397276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II.
    Al Teneiji A; Bruun TU; Sidky S; Cordeiro D; Cohn RD; Mendoza-Londono R; Moharir M; Raiman J; Siriwardena K; Kyriakopoulou L; Mercimek-Mahmutoglu S
    Mol Genet Metab; 2017 Mar; 120(3):235-242. PubMed ID: 28122681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yeast Models of Phosphomannomutase 2 Deficiency, a Congenital Disorder of Glycosylation.
    Lao JP; DiPrimio N; Prangley M; Sam FS; Mast JD; Perlstein EO
    G3 (Bethesda); 2019 Feb; 9(2):413-423. PubMed ID: 30530630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial diagnosis of the congenital disorder of glycosylation PMM2-CDG (CDG1a) in a 4-year-old girl after neurosurgical intervention for cerebral hemorrhage.
    Stefanits H; Konstantopoulou V; Kuess M; Milenkovic I; Matula C
    J Neurosurg Pediatr; 2014 Nov; 14(5):546-9. PubMed ID: 25192236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Analysis of Variants in the General Population Reveals That
    Citro V; Cimmaruta C; Monticelli M; Riccio G; Hay Mele B; Cubellis MV; Andreotti G
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anesthetic management of a child with phosphomannomutase-2 congenital disorder of glycosylation (PMM2-CDG).
    Sakai W; Yoshikawa Y; Tokinaga Y; Yamakage M
    JA Clin Rep; 2017; 3(1):8. PubMed ID: 29492447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From gestalt to gene: early predictive dysmorphic features of PMM2-CDG.
    Martinez-Monseny A; Cuadras D; Bolasell M; Muchart J; Arjona C; Borregan M; Algrabli A; Montero R; Artuch R; Velázquez-Fragua R; Macaya A; Pérez-Cerdá C; Pérez-Dueñas B; Pérez B; Serrano M;
    J Med Genet; 2019 Apr; 56(4):236-245. PubMed ID: 30464053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetazolamide treatment in late onset CDG type 1 due to biallelic pathogenic DHDDS variants.
    Mousa J; Veres L; Mohamed A; De Graef D; Morava E
    Mol Genet Metab Rep; 2022 Sep; 32():100901. PubMed ID: 36046393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient reported outcomes for phosphomannomutase 2 congenital disorder of glycosylation (PMM2-CDG): listening to what matters for the patients and health professionals.
    Pascoal C; Ferreira I; Teixeira C; Almeida E; Slade A; Brasil S; Francisco R; Ligezka AN; Morava E; Plotkin H; Jaeken J; Videira PA; Barros L; Dos Reis Ferreira V
    Orphanet J Rare Dis; 2022 Oct; 17(1):398. PubMed ID: 36309700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation and first report of dilated cardiomyopathy in ALG6-CDG (CDG-Ic): a case report.
    Al-Owain M; Mohamed S; Kaya N; Zagal A; Matthijs G; Jaeken J
    Orphanet J Rare Dis; 2010 Apr; 5():7. PubMed ID: 20398363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.